Merck Vaccines Pipeline Gets Boost Via Deal for Opko Candidate for Epstein-Barr
Epstein-Barr is among the most common viruses, but no vaccines are available to prevent its infection. Merck is joining the pursuit for a vaccine by striking a deal with Opko Health, paying $50 million…
Continue Reading